Document is current
Any future updates will be listed below
-
Authors
Boettcher, Michael
Thomas, Dirk
Mueck, Wolfgang
Loewen, Stephanie
Arens, Erich
Yoshikawa, Kenichi
Becker, Corina http://orcid.org/0000-0003-4715-6726
-
Funding
Funding for this research was provided by:
Bayer AG
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA
- License Information
-
More Information
Article History
Received: 8 June 2020
Accepted: 14 October 2020
First Online: 30 October 2020
Compliance with ethical standards
:
: M. Boettcher, W. Mueck, D. Thomas, and C. Becker are employees of Bayer AG and may own stock in the company.K. Yoshikawa is an employee of Bayer Yakuhin, Ltd.S. Loewen is an employee of Chrestos Concept GmbH & Co. KG and a paid consultant for Bayer AG.E. Arens was an employee of Bayer AG at the time the studies were conducted.
: Studies met all local legal and regulatory requirements and were conducted in accordance with the currently accepted version of the Declaration of Helsinki, the International Conference on Harmonisation Good Clinical Practice Guideline, the European Union Directive 2001/20/EC, and the German Drug Law (Arzneimittelgesetz).
: Written informed consent was obtained from individuals in each study.
: All authors drafted the article and/or revised it critically for important intellectual content and provided final approval of the published version.
